Is adsorption an important characteristic of dialysis membranes?

Kidney International

Volumn 49, Issue 2, 1996, Pages 309-313

  Pascual, Manuel ^a   Tolkoff Rubin, Nina ^b   Schifferli, Jürg A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA MICROGLOBULIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR D; COMPLEMENT MEMBRANE ATTACK COMPLEX; CUPROPHANE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 6; LOW MOLECULAR WEIGHT PROTEIN; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYAMIDE; POLYSULFONE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADSORPTION; BIOCOMPATIBILITY; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LEUKOPENIA; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

EID: 0030054247     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.47     Document Type: Article

References (60)

1. HAKIM RM: Clinical implications of hemodialysis biocompatibility. Kidney Int 44:484-494, 1993
2. LAZARUS JM, OWEN WF: Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 24:1019-1032, 1994
3. SCHULMAN G, HAKIM R, ARIAS R, SILVERBERG M, KAPLAN AP, ARBEIT L: Bradykinin generation by dialysis membranes: Possible role in anaphylactic reaction. J Am Soc Nephrol 3:1563-1569, 1993
4. SCHIFFL H, LANG SM, KONIG A, STRASSER T, HAIDER MC, HELD E: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344:570-572, 1994
5. HAKIM RM, WINGARD RL, PARKER RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331:1338-1342, 1994
6. HAKIM RM, TOLKOFF-RUBIN N, HIMMELFARB J, WINGARD RL, PARKER RA: A multicenter comparison of bioincompatible and biocompatible membranes in the treatment of acute renal failure. (abstract) J Am Soc Nephrol 5:394, 1994
7. KAPLAN AA, PAGANINI EP, BOSCH JP: Effect of the dialysis membrane in acute renal failure. N Engl J Med 332:961, 1995
8. SCHULMAN G, FOGO A, GUNG A, BADR K, HAKIM RM: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40:1069-1074, 1991
9. KELLY KJ, WILLIAMS WW, COLVIN RB, BONVENTRE JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812-816, 1994
10. ARNAOUT MA, HAKIM RM, TODD RF, DANA N, COLTEN HR: Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 312:457-462, 1985
11. HIMMELFARB J, ZAOUI P, HAKIM RM: Modulation of granulocyte LAM-1 and MAC-1 during dialysis - A prospective, randomized controlled trial. Kidney Int 41:388-395, 1992
12. HAKIM R, FEARON DT, LAZARUS JM: Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 26:194-200, 1984
13. CHEUNG AK, PARKER CJ, HOHNHOLT M: Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro. Kidney Int 46:1680-1687, 1994
14. BOK DV, PASCUAL L, HERBERGER C, LEVIN NW: Effect of multiple use of dialyzers on intradialytic symptoms. Proc Clin Dial Transplant Forum 10:92-98, 1980
15. ROBSON MD, CHAROENPANICH R, KANT KS: Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer use. Am J Nephrol 6:101-106, 1986
16. HAKIM RM, BREILLAT J, LAZARUS JM, PORT FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311:878-882, 1984
17. VAN YPERSELE DE STRIHOU, JADOUL M, MALGHEM J, MALDAGUE B, JAMART J, THE WORKING PARTY ON DIALYSIS AMYLOIDOSIS: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 39:1012-1019, 1991
18. CHANDRAN PKG, LIGGETT R, KIRKPATRICK B: Patient survival on PAN/AN69 membrane hemodialysis: A ten year analysis. J Am Soc Nephrol 4:1199-1204, 1993
19. CHARRA B, CALEMARD E, RUFFET M, CHAZOT C, TERRAT JC, VANEL T, LAURENT G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
20. BONOMINI V, COLLI G, FELICIANGELI G, MOSCONI G, SCOLARI MP: Long term results: Cellulosic versus synthetic membranes. Contrib Nephrol 113:120-134, 1995
21. CHENOWETH DE, CHEUNG AK, WARD DM, HENDERSON LW: Anaphylatoxin formation during hemodialysis: Comparison of new and re-used dialyzers. Kidney Int 24:770-774, 1983
22. KUWAHARA T, MARKERT M, WAUTERS JP: Proteins adsorbed on hemodialysis membranes modulate neutrophil activation. Artif Organs 13:427-431, 1989
23. CHEUNG AK, PARKER CJ, JANATOVA J: Analysis of the complement C3 fragments associated with hemodialysis membranes. Kidney Int 35:576-588, 1989
24. KUWAHARA T, MARKERT M, WAUTERS JP: Biocompatibility aspects of dialyzer reprocessing: A comparison of 3 re-use methods and 3 membranes. Clin Nephrol 32:139-143, 1989
25. CHEUNG AK: Adsorption of unactivated complement proteins by hemodialysis membranes. Am J Kidney Dis 14:472-477, 1989
26. AMADORI A, CANDI P, SASDELLI M, MASSAI G, FAVILLA S, PASSALEVA A, RICCI M: Hemodialysis leukopenia and complement function with different dialyzers. Kidney Int 24:775-781, 1983
27. D'AMOUR P, JOBIN J, HAMEL L, L'ECUYER N: iPTH values during hemodialysis: Role of ionized calcium, dialysis membranes and iPTH assays. Kidney Int 38:308-314, 1990
28. ORLOFF JJ, SOIFER NE, FODERO JP, DANN P, BURTIS WJ: Accumulation of carboxy-terminal fragments of parathyroid hormone-related protein in renal failure. Kidney Int 43:1371-1376, 1993
29. CHEUNG AK: Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1:150-161, 1990
30. MOORE B, WALSH J, SCHULMAN G, ARBEIT L: Polyacrylonitrile dialysis membranes scavenge C3a desarg in man. (abstract) Kidney Int 35:256, 1989
31. VOLANAKIS JE, BARNUM SR, GIDDENS M, GALLA JH: Renal filtration and catabolism of complement protein D. N Engl J Med 312:395-399, 1985
32. PASCUAL M, STEIGER G, ESTREICHER J, MACON K, VOLANAKIS JE, SCHIFFERLI JA: Metabolism of complement factor D in renal failure. Kidney Int 34:529-536, 1988
33. DEPPISCH R, RITZ E, HÄNSCH GM, SCHÖLS M, RAUTERBERG EW: Bioincompatibility: Perspectives in 1993. Kidney Int 45(Suppl 44):S77-S84, 1994
34. HAEFFNER-CAVAILLON N, CAVAILLON JM, LAUDE MD, KAZATCHKINE MD: C3a/C3a desarg induces production and release of interleukine 1 by cultured human monocytes. J Immunol 139:794-799, 1987
35. DEPPISCH R, SCHMITT V, BOMMER J, HANSCH G, RITZ E, RAUTERBERG EW: Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int 37:696-706, 1990
36. PERTOSA G, TARANTINO EA, GESUALDO L, MONTINARO V, SCHENA FP: C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int 43(Suppl 41):S221-S225, 1993
37. VANHOLDER R, RINGOIR S, DHONDT A, HAKIM R: Phagocytosis in uremic and hemodialyzed patients: A prospective and cross-sectional study. Kidney Int 39:320-327, 1991
38. KOCH KM: Dialysis-related amyloidosis. Kidney Int 41:1416-1429, 1992
39. SCHINDLER R, LINNENWEBER S, SCHULZE M, OPPERMANN M, DINARELLO CA, SHALDON S, KOCH KM: Gene expression of interleukin-1β during hemodialysis. Kidney Int 43:712-721, 1993
40. CANIVET E, LAVAUD S, WONG T, GUEUNOUNOU M, WILLEMIN JC, POTRON G, CHANARD J: Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis 23:41-46, 1994
41. PASCUAL M, CATANA M, WHITE T, SPIEGELMAN BM, SCHIFFERLI JA: Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D. Eur J Immunol 23:1389-1392, 1993
42. PASCUAL M, SCHIFFERLI JA: Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 43:903-911, 1993
43. PASCUAL M, SCHIFFERLI JA, PANNATIER JG, WAUTERS JP: Removal of complement factor D by adsorption on polymethylmethacrylate dialysis membranes. Nephrol Dial Transplant 8:1305-1306, 1993
44. BONE RC: The pathogenesis of sepsis. Ann Int Med 115:457-469, 1991
45. CHEUNG AK, PARKER CJ, WILKOX LA, JANATOVA J: Activation of complement by hemodialysis membranes: Polyacrilonitrile binds more C3a than cuprophan. Kidney Int 37:1055-1059, 1990
46. SCHULMAN G, HAKIM RM: Recent advances in the biocompatibility of hemodialysis membranes. Nephrol Dial Transplant 6(Suppl 2):10-13, 1991
47. LONEMANN G, KOCH K, SHALDON S, DINARELLO CA: Studies on the ability of the hemodialysis membranes to induce, bind, and clear human interleukin-1. J Lab Clin Med 112:76-86, 1988
48. COTTRELL AC, MEHTA RL: Cytokine kinetics in septic acute renal failure patients on continuous veno-veno hemodialysis (CVVHD). (abstract) J Am Soc Nephrol 3:361, 1992
49. ABRAHAM E, WUNDERINK R, SILVERMAN H, PERL TM, NASRAWAY S, LEVY H, BONE R, WENZEL RP, BALK R, ALFRED R, PENNINGTON JE, WHERRY JC, FOR THE TNF-ALPHA MAB SEPSIS STUDY GROUP: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 273:934-941, 1995
50. DINARELLO CA: Cytokines: Agents provocateurs in hemodialysis? Kidney Int 41:683-694, 1992
51. SCHARDIJN GHC, STATIUS VAN EPS LW: β2-microglobulin: Its significance in the evaluation of renal function. Kidney Int 32:635-641, 1987
52. VANDENBROUCKE JM, JADOUL M, MALDAGUE B, HUAUX JP, NOEL H, VAN YPERSELE DE STRIHOU C: Possible role of dialysis membrane characteristics in amyloid osteoarthropathy. Lancet i:1210-1211, 1986
53. HAUGLUSTAINE D, WAER M, MICHIELSEN P, GOEBELS J, VANDENPUTTE M: Hemodialysis membranes, serum β2-microglobulin, and dialysis amyloidosis. Lancet i:1211-1212, 1986
54. CHANARD J, LAVAUD S, TOUPANCE O, MELIN JP, GILLERY P, REVILLARD JP: β2-microglobulin-associated amyloidosis in chronic hemodialysis patients. Lancet i:1212, 1986
55. GOLDMAN M, DHAENE M, VANHERWEGHEM JL: Removal of β2-microglobulin by adsorption on dialysis membranes. Nephrol Dial Transplant 2:576-577, 1987
56. KLINKE B, ROCKEL A, ABDELHAMID S, FIEGEL P, WALB D: Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes. Int J Artif Organs 12:697-702, 1989
57. DAVID S, CANINO F, FERRARI ME, CAMBI V: The role of adsorption in β2-microglobulin removal. Nephrol Dial Transplant 6(Suppl 2):64-68, 1991
58. CIVATI G, GUASTONI G, TEATINI U, PEREGO A, PERRINO ML, BENAZZI: High-flux acetate hemodialysis: A single centre experience. Nephrol Dial Transplant 6(Suppl 2):75-81, 1991
59. GOLDMAN M, LAGMICHE M, DHAENE M, AMRAOUI Z, THAYSE C, VANHERWEGHEM JL: Adsorption of beta 2-microglobulin on dialysis membranes: Comparison of different dialyzers and effects of reuse procedures. Int J Artif Organs 12:373-378, 1989
60. BOULTON-JONES M: Dialysis membranes: Clinical effects. Lancet 344:559, 1994